Cash, Cash Equivalents, and Restricted Cash and Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Cash and Cash Equivalents

The following table reflects the Company’s cash equivalents and restricted cash equivalents, which consisted of money market funds held in sweep and asset management accounts:

	March 31, 2023		December 31, 2022
	(In thousands)
Cash equivalents (1)	$	321,230	$	300,969
Restricted cash equivalents (2)	13,873		—
Total cash equivalents and restricted cash equivalents	$	335,103	$	300,969

_________________________________________________

(1)    Included in cash and cash equivalents in the Condensed Consolidated Balance Sheets.

(2)    Included in other current assets in the Condensed Consolidated Balance Sheets.

Schedule of Restricted Cash Equivalents

The following table reflects the Company’s cash equivalents and restricted cash equivalents, which consisted of money market funds held in sweep and asset management accounts:

	March 31, 2023		December 31, 2022
	(In thousands)
Cash equivalents (1)	$	321,230	$	300,969
Restricted cash equivalents (2)	13,873		—
Total cash equivalents and restricted cash equivalents	$	335,103	$	300,969

_________________________________________________

(1)    Included in cash and cash equivalents in the Condensed Consolidated Balance Sheets.

(2)    Included in other current assets in the Condensed Consolidated Balance Sheets.